Consultant profile

Mr Aniruddha Chakravarti qualified as a medical graduate in 1990 and attained post-graduate training in general surgery before embarking on an extensive training in Urology. In addition to his experience in General Urology, Mr Chakravarti has developed a special interest in Robotic and Laparoscopic surgery of the upper urinary tract and all surgical procedures for benign prostatic enlargement including all types of laser surgery and UROLIFT procedure and stone disease.

He has received intensive laparoscopy training from the European Institute of Telesurgery in Strasbourg, France, and has obtained a Diploma in Laparoscopic Surgery from the Institute.

Mr Chakravarti works as a Consultant Urological Surgeon at the Royal Wolverhampton Hospitals NHS Trust and regularly performs da Vinci Robot-assisted and pure laparoscopic surgery of the upper urinary tract to provide a service for treating kidney cancers.

He has also been through intensive training and has over four years of experience of using all kinds of lasers for prostatic surgery and is one of the few surgeons experienced in Holmium-YAG laser enucleation and morcellation of prostate as well as the least invasive UROLIFT procedure in suitable cases.

A primary advantage of HoLEP over other laser prostatectomy techniques is that it can rapidly create a large cavity by immediately removing obstructing tissue, rendering it suitable for large prostates of up to 100 grams. The coagulative ability of the holmium laser effectively seals tissue planes as the operation progresses, which makes HoLEP a relatively bloodless operation with a concomitant reduction in transfusion requirement, and also avoids the dangers of systemic fluid absorption.

The principal advantage of the UROLIFT procedure is providing symptom relief while maintaining sexual function and the procedure is mostly done as a day case with no catheter required at the end of the procedure.

Mr Chakravarti has a keen interest in clinical research and has been a principal investigator in a number of international clinical trials. He is currently working with the National Institute of Health Research and is also an expert advisor for the National Institute for Health and Care Excellence.